Skip to content

Management of Rheumatoid Arthritis.

Management Of Rheumatoid Arthritis With Individualised Homoeopathy: An Observational Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/01/011192
Enrollment
160
Registered
2018-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Rheumatoid Arthritis

Interventions

None listed

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor
Dr Jaya Gupta
Collaborator
Dr Ritika Hassija Narula
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: i. Cases with score more than or equal to 6 as per ACR/EULAR 2010 criteria ii. Patients with low and moderate activity of DAS 28- CRP score iii. Patient not under any conventional treatment for RA except those on occasional painkillers iv. Controlled cases of Diabetes, Hypertension and Hypothyroidism fulfilling above criteria

Exclusion criteria

Exclusion criteria: i. Cases having any other joint affection/Arthritis ii. Pregnancy and Lactation iii. RA patients with extensive joint deformity(more than or in 3 joints) iv. Patients under conventional treatment for RA including DMARDs v. Patient not giving consent vi. Any patient not deemed fit by the investigator

Design outcomes

Primary

MeasureTime frame
To assess and compare the changes in the DAS 28 CRP score from baseline, at 3rd, 6th, 9th and 12th month in Clinical improvement of Rheumatoid ArthritisTimepoint: Baseline, 3rd month, 6th month, 9 month and end of 1 yr.

Secondary

MeasureTime frame
To assess and compare the changes in activity profile and quality of life of Rheumatoid Arthritis patients using ACR 20 response criteriaTimepoint: Baseline, every month and at end of 1 yr.

Countries

India

Contacts

Public ContactDr Ritika Hassija Narula

Central Council for Research in Homoeopathy

jgupta21@gmail.com011-28525523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026